HUTCHMED (China) HMDCF
NASDAQ HMDCF
$2.16 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

HUTCHMED (China) (HMDCF) Accumulated Expenses (2015 - 2026)

HUTCHMED (China)'s (HMDCF) quarterly Accumulated Expenses came in at $197.6 million in Q2 2026, down 10.6% year-over-year from $221.1 million in Q2 2025, and down 10.6% quarter-over-quarter from $221.1 million in Q2 2025.

Analysis

HUTCHMED (China) (HMDCF) Accumulated Expenses (2015 - 2026) Analysis & Trends

HUTCHMED (China) (HMDCF) has reported Accumulated Expenses for 11 consecutive years, with $197.6 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Accumulated Expenses fell 10.6% year-over-year to $197.6 million in Q2 2026; TTM through Jun 2026 was $197.6 million, a 10.6% decrease from a year earlier, with the FY2022 full-year figure at $52.6 million, down 75.04% from the prior year.
  • Accumulated Expenses was $197.6 million for Q2 2026 at HUTCHMED (China), down from $221.1 million in the prior quarter.
  • Over five years, Accumulated Expenses peaked at $249.2 million in Q2 2024 and troughed at $52.6 million in Q4 2022.
  • A 4-year average of $180.1 million and a median of $209.3 million in 2025 frame the typical range for Accumulated Expenses.
  • Across the five-year window, Accumulated Expenses declined 20.53% in 2022 and retreated 10.6% in 2026, its largest moves.
  • Over 4 years, Accumulated Expenses stood at $52.6 million in 2022, then soared by 373.54% to $249.2 million in 2024, then dropped by 11.3% to $221.1 million in 2025, then dropped by 10.6% to $197.6 million in 2026.
  • The last three Accumulated Expenses figures came in at $197.6 million (Q2 2026), $221.1 million (Q2 2025), and $249.2 million (Q2 2024), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 211.50 Bn 197.51 Bn 7.24 Bn
2 Gilead Sciences 181.29 Bn 178.11 Bn 6.22 Bn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 82.55 Bn 74.56 Bn 3.93 Bn
5 Argenx Se 61.65 Bn 56.47 Bn 1.37 Bn
6 Moderna 54.65 Bn 49.52 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 34.18 Bn 30.87 Bn 992.69 Mn
8 Biogen 31.36 Bn 30.07 Bn 1.96 Bn
9 Roivant Sciences 30.01 Bn 30.01 Bn 1.16 Mn
10 HUTCHMED (China) 376.85 Mn 391.04 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 197.63 Mn
Jun 30, 2025 221.06 Mn
Jun 30, 2024 249.22 Mn
Dec 31, 2022 52.63 Mn
Dec 31, 2021 66.22 Mn
Mar 31, 2021 150.33 Mn
Dec 31, 2020 37.47 Mn
Mar 31, 2020 1.06 Mn
Dec 31, 2019 25.95 Mn
Sep 30, 2019 74.75 Mn
Mar 31, 2019 64.16 Mn
Dec 31, 2018 16.29 Mn
Dec 31, 2017 5.19 Mn
Jun 30, 2017 27.65 Mn
Dec 31, 2016 7.55 Mn
Jun 30, 2016 23.68 Mn
Dec 31, 2015 4.66 Mn
Jun 30, 2015 326,000.00